177 related articles for article (PubMed ID: 37078062)
1. Self-transfecting GMO-PMO chimera targeting
Das U; Kundu J; Shaw P; Bose C; Ghosh A; Gupta S; Sarkar S; Bhadra J; Sinha S
Mol Ther Nucleic Acids; 2023 Jun; 32():203-228. PubMed ID: 37078062
[TBL] [Abstract][Full Text] [Related]
2. Internal Oligoguanidinium Transporter: Mercury-Free Scalable Synthesis, Improvement of Cellular Localization, Endosomal Escape, Mitochondrial Localization, and Conjugation with Antisense Morpholino for NANOG Inhibition to Induce Chemosensitization of Taxol in MCF-7 Cells.
Kundu J; Banerjee P; Bose C; Das U; Ghosh U; Sinha S
Bioconjug Chem; 2020 Oct; 31(10):2367-2382. PubMed ID: 32986398
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Self Permeable Antisense PMO Using C5-Guanidino-Functionalized Pyrimidines at the 5'-End Enables Sox2 Downregulation in Triple Negative Breast Cancer Cells.
Das A; Gupta S; Shaw P; Sinha S
Mol Pharm; 2024 Mar; 21(3):1256-1271. PubMed ID: 38324380
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 5'-Thiol Functionalized Morpholino Oligo-Nucleotide and Subsequent Conjugation with IGT to Improve Delivery and Antisense Efficacy
Ghosh U; Gupta S; Sinha S
Bioconjug Chem; 2023 Jan; 34(1):174-180. PubMed ID: 36538654
[TBL] [Abstract][Full Text] [Related]
5. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.
Nan Y; Zhang YJ
Front Microbiol; 2018; 9():750. PubMed ID: 29731743
[TBL] [Abstract][Full Text] [Related]
6. AUF-1 knockdown in mice undermines gut microbial butyrate-driven hypocholesterolemia through AUF-1-Dicer-1-mir-122 hierarchy.
Das O; Kundu J; Ghosh A; Gautam A; Ghosh S; Chakraborty M; Masid A; Gauri SS; Mitra D; Dutta M; Mukherjee B; Sinha S; Bhaumik M
Front Cell Infect Microbiol; 2022; 12():1011386. PubMed ID: 36601302
[TBL] [Abstract][Full Text] [Related]
7. Construction of nanostructured DNA harbouring phosphorodiamidate morpholino oligonucleotide for controlled tissue distribution in mice.
Takahashi Y; Araie Y; Nomura D; Takahashi Y; Sano K; Saji H; Takakura Y; Nishikawa M
J Drug Target; 2018 Apr; 26(4):373-381. PubMed ID: 28972806
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
[TBL] [Abstract][Full Text] [Related]
9. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
[TBL] [Abstract][Full Text] [Related]
10. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.
Moulton HM; Hase MC; Smith KM; Iversen PL
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):31-43. PubMed ID: 12691534
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of
Falzarano MS; Argenziano M; Marsollier AC; Mariot V; Rossi D; Selvatici R; Dumonceaux J; Cavalli R; Ferlini A
Nucleic Acid Ther; 2021 Jun; 31(3):201-207. PubMed ID: 32679000
[TBL] [Abstract][Full Text] [Related]
12. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers.
Ghosh C; Iversen PL
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):263-74. PubMed ID: 10984120
[TBL] [Abstract][Full Text] [Related]
13. Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
Wang M; Wu B; Tucker JD; Lu P; Lu Q
Int J Nanomedicine; 2015; 10():5635-46. PubMed ID: 26366082
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Phosphorodiamidate Morpholino Oligonucleotides and Their Chimeras Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
J Am Chem Soc; 2016 Dec; 138(48):15663-15672. PubMed ID: 27934012
[TBL] [Abstract][Full Text] [Related]
15. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
[TBL] [Abstract][Full Text] [Related]
16. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
Geller BL; Deere J; Tilley L; Iversen PL
J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
[TBL] [Abstract][Full Text] [Related]
18. Development of novel bioanalytical methods to determine the effective concentrations of phosphorodiamidate morpholino oligomers in tissues and cells.
Schnell FJ; Crumley SL; Mourich DV; Iversen PL
Biores Open Access; 2013 Feb; 2(1):61-6. PubMed ID: 23515175
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Vesivirus infections in mammalian tissue culture with antisense morpholino oligomers.
Stein DA; Skilling DE; Iversen PL; Smith AW
Antisense Nucleic Acid Drug Dev; 2001 Oct; 11(5):317-25. PubMed ID: 11763348
[TBL] [Abstract][Full Text] [Related]
20. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
